United States · FDA National Drug Code directory
Orbactiv
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70842-140_4c7649f3-4d38-47e2-aa0d-2ed606bb930a
- Product NDC
- 70842-140
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- oritavancin
- Labeler
- Melinta Therapeutics, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140901
- Source listing expiry
- 20261231
Source-listed ingredients
- ORITAVANCIN — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 VIAL, GLASS in 1 CARTON (70842-140-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70842-140-01) · 70842-140-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →